Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis

Clinical trial NCT01571297 · COMPLETED

Trial details

NCT number: NCT01571297
Sponsor: Motus Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Diabetes Mellitus Complications Gastroparesis

Start date: 2012-04-01
Primary completion: 2013-08-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.